Bumble is set to become the first dating app to have a brick-and-mortar storefront. In a recent press release, the company announced that it will open its first physical space in New York City. The pop-up space will act as a place for dates to meet and know each other more. The space will be open to the fans of Bumble and anyone interested in hanging out.
The space is specially designed to bring out the Bumble’s unique flavor. It is also the company’s first step towards formalizing the Bumble community. The move comes at a time when some dating apps are considered taboo by the society. According to Whitney Wolfe, the brand is now more than just a dating app. The public will be proud to be associated with it. Whitney is the app’s founder.
The creation of a Bumble physical space also integrated with the company’s plan of expanding BumbleBIZZ. Through the unit, the brand hopes to venture into professional and social networking. Individuals who are not in need of a date can use BumbleBIZZ as they may be looking for business partners or friends to join their circles.
The Bumble physical space will be open for the next one month. In this period, couples will be free to visit it for a date, while friends can visit to hang out during the week. The space will also host other events. Wolfe will be hoisting a panel of the founders of the Skimm at the property. In addition, Drybar will host an event at the space. This will be followed by another event by Forbes’s Mentor and Mingle session.
About Whitney Wolfe
Whitney Wolfe is a revered American executive and a shrewd entrepreneur. She is the chief executive officer of Bumble, a dating app. The entrepreneur is also the brain behind Tinder. Wolfe’s business success has seen Forbes name her in its 2017 list of Forbes 30 Under 30. In 2016, she was named in Elle’s Women in Tech.
Over the years, Whitney Wolfe launched Bumble in 2014. The dating app has gained popularity. Presently, it has over 11.5 million users. The other brands that are owned by the company include BumbleBizz and BumbleFF. Whitney Wolfe was born in Salt Lake City, Utah. She holds a degree in International Studies from Southern Methodist University.
Scott M. Rocklage is a managing partner at 5AM Ventures and based out of Boston, Massachusetts. He was hired by the company in 2003 as a Venture Partner before he was promoted to his current position a year later in 2004. Learn more about Scott Rocklage: http://www.rennovia.com/team/scott-m-rocklage/
In the past he studied at both the University of California, Berkeley Campus and the Massachusetts Institute of Technology where he earned a Bachelors Degree in Chemistry and a PhD in Chemistry respectively. In addition to everything he learned from college, Rocklage also has over three decades of experience in healthcare management. This experience was used to gain FDA approval of the U.S. New Drug Applications for Omniscan, Teslascan and Cubicin. Read more: Scott Racklage | Crunchbase
Before becoming a managing partner for 5AM Ventures, Scott Rocklage served and continues to serve as the CEO and Chairman of Cubist Pharmaceuticals, the CEO and President of Nycomed Salutar, the Board Chairman of Cidara, Rennovia and Kinestral and Board Member of Epirus and Pulmatrix.
He has also been a driving force behind companies such as Catalytica, Relypsa, Miikana, Semprus, Ilypsa and Novira. When he is not completing his duties as a Board Member or as a managing partner Rocklage enjoys inventing. He has been part of over 30 U.S. patents and has over 100 peer-reviewed publications.
Scott Rocklage created 5AM Ventures to put everything he has learned to good use. The inspiration to start his own company came from his love of all things science and his background in capital ventures. Each day at 5AM Ventures is a new adventure. Some days are spent delving into new studies in the fields of chemistry and other life sciences while others are working with prospective companies by looking over their portfolios or teaching their management teams.
Rocklage also attends numerous 5AM Venture Board meetings, which are a common occurrence for a company that is still growing. Rocklage hopes that by combining all of these factors his company can really make a difference in the world. His biggest ambition is for 5AM Venture to be part of the team that is able to target specific mutations or genotypes in an attempt to find a cure for cancer.
Learn more about Scott Rocklage: http://chemistry.mit.edu/scott-rocklage-phd-2-and-his-wife-patty-are-celebrated-their-major-gift